Davison Daniel Paul 4
4 · Diplomat Pharmacy, Inc. · Filed Feb 10, 2020
Insider Transaction Report
Form 4
Davison Daniel Paul
Chief Financial Officer
Transactions
- Disposition to Issuer
Employee Stock Option to Acquire Common Stock
2020-02-10−87,478→ 0 totalExercise: $405.90Exp: 2029-04-08→ Common Stock (87,478 underlying) - Disposition to Issuer
Common Stock
2020-02-10−43,209→ 200,000 total - Disposition to Issuer
Common Stock
2020-02-10−200,000→ 0 total
Footnotes (2)
- [F1]Pursuant to an Agreement and Plan of Merger, dated December 9, 2019 (the "Merger Agreement"), by and among UnitedHealth Group Incorporated, a Delaware corporation ("Parent"), Purchaser, a Michigan corporation and a wholly owned subsidiary of Parent and Diplomat Pharmacy, Inc., a Michigan corporation (the "Issuer"), certain outstanding restricted stock unit awards held by reporting person were converted into equity awards of the Parent pursuant to the closing on February 10, 2020 of the merger of Purchaser with and into the Issuer. These shares remain subject to time-based vesting requirements.
- [F2]One-third of the options vest on each of the first, second and third anniversary of the grant date (April 8, 2019).